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DISSERTATION ABSTRACT 
Background and objective: Strain counterstrain (SCS) is an osteopathic technique used by 
osteopaths and manual therapists for the relief of musculoskeletal pain and associated 
dysfunction. Limited literature exists to support the efficacy of SCS technique. This dissertation is 
presented in two sections. Section one is a literature review of SCS technique and the proposed 
outcome measures. Section two is the research conducted presented as a manuscript in the style 
required by the International Journal of Osteopathic Medicine. The second section is supported 
by three appendices of material not intended for publication. The aim of this study was to 
investigate the efficacy of SCS technique on subjects with a history of a recreational sports injury 
of the upper extremity.  
 
Design: Randomized assessor blinded placebo controlled trial. 
 
Methods: Twenty three subjects (13 males, 10 females; mean age=26.1, SD=6.3) fulfilled the 
requirements for the study. Subjects were screened to establish the presence of a primary tender 
point (TeP) around the elbow joint. Subjects were randomly assigned into two groups and 
received either an SCS intervention or a Sham intervention. The primary outcome measures were 
pressure pain threshold (PPT) on the primary TeP, and visual analog scale (VAS) assessing local 
pain intensity elicited by the application of approximately 3kg/cm2 of pressure on the primary TeP. 
The secondary outcome measure was pain-free grip strength (PFGS). 
 
Results: Within group changes showed a significant improvement in VAS for pain intensity 
following the SCS intervention (p<0.001) compared with the Sham intervention (p=0.053). Pre-
post effect sizes for the VAS for pain intensity were ‘large’ in the SCS intervention group (d=1.87) 
and ‘moderate’ (d=0.90) for the Sham intervention group. Both groups surpassed the minimal 
clinically important difference (MCID) defined as a decrease ≥30% in VAS for pain intensity (SCS 
group=55%, Sham group=31%). Within group changes showed a small improvement for PPT at 
the TeP following either the SCS intervention (p=0.497) compared with the sham intervention 
(p=0.749). Pre-post effect sizes for the TeP were small in the SCS intervention group (d=0.29) 
and trivial (d=0.14) for the sham intervention group. No significant differences were found for the 
PFGS (SCS: p=0.936 d=0.03, Sham: p=0.989 d=0.01) 
 
Conclusions: The results indicate that SCS technique may be an efficacious technique in 
treatment of TePs around the elbow in subjects with a history of a recreational sports injury of the 
upper extremity. SCS technique can produce decreases in pain intensity as reported from 
mechanical pressure at a primary TeP. 
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Introduction 
Strain-counterstrain (SCS) is an osteopathic treatment technique first developed and described 
by Lawrence Jones in 1964 (L. H. Jones, 1981). Strain-counterstrain, also known as positional 
release, is an indirect osteopathic technique, whereby dysfunctional joints and their muscles are 
moved away from their restrictive barriers into positions of ease in the treatment of both 
musculoskeletal (D'Ambrogio & Roth, 1997; L. H. Jones, 1981; Ward, 2003) and visceral 
dysfunctions (Giammatteo & Weiselfish-Giammatteo, 1997). Since Jones’ first description there 
has been a variety of anecdotal evidence presented by assorted therapists in support of the 
technique but only limited experimental evidence to demonstrate it’s efficacy in the treatment of 
musculoskeletal pain and related joint dysfunction (D'Ambrogio & Roth, 1997; Giammatteo & 
Weiselfish-Giammatteo, 1997; L. H. Jones, 1981; Ward, 2003). 
 
The application of SCS technique requires a practitioner to first palpate a tender point (TeP) in 
the soft tissues, the patient’s limb is then moved in such a way that the pain associated with 
pressure on the TeP is relieved by at least 70 percent to find the position of ease (D'Ambrogio & 
Roth, 1997; L. H. Jones, 1981; McPartland & Goodridge, 1997; Wong & Schauer-Alvarez, 2004; 
Wong & Schauer, 2004). Jones (1981) suggested a minimum period required to hold a position of 
ease as 90 seconds. It is theorized that the shortening or “folding-over” of aberrant tissues in SCS 
technique achieves its therapeutic modifications via both proprioceptive (Korr, 1975) and 
nociceptive mechanisms (Bailey & Dick, 1992), or by the biomechanical principle of 
nonsequential motion expounded by McPartland & Klofat (1995). 
 
Bailey & Dick (1992) proposed a nociceptive hypothesis that tissue damage in dysfunctional 
muscles can be reduced by the positional release mechanism utilized by SCS. They suggest that 
relaxation of the damaged tissues may be achieved by placing patients in a position of ease 
which may advance local perfusion of fluids (i.e. blood, and lymph) and enhance the removal of 
sensitizing inflammatory mediators. 
 
In order to use SCS technique a practitioner needs to be able to accurately identify a painful TeP. 
The TeP can be interpreted using anatomical charts (D'Ambrogio & Roth, 1997; L. H. Jones, 
1981) or the “Paracelsus approach” (McPartland & Klofat, 1995), probing a region of patient’s 
pain complaint with the practitioners thumb or finger to locate sensitive TeP’s. McPartland & 
Goodridge (1997) found the SCS method of palpatory diagnosis to be more reliable compared to 
a traditional osteopathic examination (the tests studied included palpation for restriction of motion, 
local tissue texture changes and joint capsule tenderness) for subjects with chronic neck pain, 
demonstrating a 72.2% (κ=0.45; ‘moderate’) agreement between examiners. 
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The essence of SCS is the relief of a painful TeP by moving the patient’s limb in order to find a 
position of ease (L. H. Jones, 1981). Total pain relief is not always the goal, a minimum level of 
70% reduction in the (short term) pain associated with the TeP is said to be expected immediately 
after treatment (D'Ambrogio & Roth, 1997; McPartland & Klofat, 1995). 
 
In 1981 Jones reported diagnostic correlations between joint dysfunction and palpable myofascial 
tissue TePs (L. H. Jones, 1981).  D’Ambrogio & Roth (1997) have subsequently published a list of 
more than 200 diagnostic TeP locations. The TePs used in SCS are described by Jones (L. H. 
Jones, 1981) as: 
The tender points used in counterstrain techniques are not located in or just 
beneath the skin as are many acupuncture points, but deeper in muscle, 
tendon, ligament, or fascia. They measure 1cm across or less, with the most 
acute point about 3mm in diameter. They may be multiple for one specific joint 
dysfunction, may extend for a few centimeters along a muscle, or may be 
arranged in a chain (such as the ones in the muscle and fascia along the 
lateral surface of the femur) (p. 28) 
 
Other definitions are similar (D'Ambrogio & Roth, 1997; McPartland & Klofat, 1995). When a 
standardized pressure of 2.6kg/cm2 is applied to a TeP it has been found to cause a localized 
sensation of pain (L. H. Jones, 1981; McPartland & Klofat, 1995). 
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Effectiveness and Efficacy of Strain-counterstrain Technique 
A comprehensive search of peer-reviewed literature analyzing the efficacy or effectiveness of 
SCS identified six experimental studies (Blanco et al., 2006; Howell, Cabell, Chila, & Eland, 2006; 
Meseguer, Fernández-de-las-Peňas, Navarro-Poza, Rodrìguez-Blanco, & Gandia, 2006; Wong & 
Schauer-Alvarez, 2004; Wong & Schauer, 2004; Wynne, Burns, Eland, Conatser, & Howell, 
2006). Three additional experimental studies were identified that utilized SCS as part of an 
investigation into osteopathic manipulative therapy (Gamber, Shores, Russo, Jimenez, & Rubin, 
2002; Noll, Degenhardt, Stuart, McGovern, & Matteson, 2004) or manual therapy (Cleland, Flynn, 
& Palmer, 2005). The paucity of peer reviewed randomized controlled trial (RCT) articles related 
to SCS necessitated reference to descriptive case studies and osteopathic and manual medicine 
texts. 
 
Wong & Schauer (2004) provided evidence of a good correlation between pain reduction (using a 
visual analog scale (VAS) as a measurement of pain intensity) and SCS pain reduction at TePs 
(using manual palpation of tender points (TePs) as a measurement). The measurement of TeP 
sensitivity was performed through manual palpation of TePs to elicit a physical response (visual 
cue) from subjects, without the aid of pressure algometry to aid reliability. In a follow up study 
Wong & Schauer-Alvarez (2004) demonstrated an increase in strength in hip musculature 
following SCS treatment, and a correlated reduction in TeP pain in those muscles.  
 
Meseguer et al. (2006) concluded that the application of SCS technique may be effective in 
producing hypoalgesia and decreased reactivity of TePs. In their study Meseguer et al (2006) 
reported moderate effect sizes (as described by Hopkins (2002)) for the VAS for pain intensity 
between pre –and post- intervention measurement following the application of either the classical 
or modified application of SCS technique (p<0.001; Cohen’s d = 1.1). In comparison their control 
group did not show any change (p=0.90; Cohen’s d = 0.01). The authors were able to 
demonstrate an immediate decrease in the sensitivity of a chosen TeP following the application of 
SCS technique (Meseguer et al., 2006). The results in this study were limited by the choice of 
outcome measure, the VAS is a valid clinical measure (Reeves, Jaeger, & Graff-Radford, 1986), 
but could have become a source of error if the subjects were biased by the ability to remember 
their previous scores due to the short time period between pre- and post- recording (Meseguer et 
al., 2006). Another potential bias in their group design was the lack of a sham intervention group 
to investigate the level of placebo attached to their procedure.  
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Wynne et al. (2006) reported mechanical changes in the peak torque following treatment by SCS 
technique for various TePs in the lower leg and foot. The treatment effect was considered by the 
authors to be greater than any changes attributed to the process of repeated measures. They 
demonstrated a decrease in symptom severity as measured by their adopted four factor ratings 
scale. The four factors were: pain, soreness, stiffness, and mobility; each factor was scored 
between 0 (no symptoms) to 9 (extreme symptoms/pain), and the researchers then summed the 
values for all subjects to give a score out of a maximum range from 0 to 36 (Wynne et al., 2006). 
This study was not satisfactorily blinded, as the sham treatment chosen was an oral placebo, 
such that most subjects who took them during the course of the cross-over trial were able to 
deduce their ineffectiveness. 
 
The data reported by Howell et al. (2006) provides evidence in support of Korr’s (1975) 
hypothesis of somatic dysfunction. Korr (1975) hypothesized that the characteristic restriction-of-
motion present in somatic dysfunction was due in part to an alteration in the sensitivity of the 
monosynaptic stretch reflex, and could therefore be reset to restore range of motion. Howell et al. 
(2006) did not follow a sufficiently rigorous methodology in order to be able to make any 
generalized claims as to the effectiveness of SCS for patient’s with Achilles’ tendonitis. Their 
procedure compares a symptomatic SCS intervention group with an asymptomatic sham 
intervention group. 
 
Blanco et al. (2006) compared a muscle energy technique (post-isometric relaxation) with SCS 
technique in asymptomatic subjects presenting with latent myofascial trigger points. The 
application of SCS technique was not described as addressing a primary TeP, but rather the 
therapist located ‘a trigger point’ in the masseter muscle and proceeded to apply the SCS 
technique. It would seem plausible to expect a technique that stretches the whole muscle to be 
more effective in an asymptomatic subject when compared to a technique usually employed to 
address somatic dysfunction such as SCS. This expectation was upheld with the results reported 
by Blanco et al. (2006), where they reported an insignificant ‘small’ effect size (d=0.32; p=0.08) 
for the immediate improvements in active mouth opening for asymptomatic subjects treated with 
SCS for a trigger point identified within the masseter muscle. Blanco et al. (2006) surmised that 
SCS technique applied to a single randomly chosen latent myofascial trigger point did not 
improve active mouth opening. The approach employed by Blanco et al. (2006) was a deviation 
from the recommended method of application for SCS technique, as defined in the regular 
literature which includes a physical examination of an area for the primary TeP (D'Ambrogio & 
Roth, 1997; L. H. Jones, 1981; McPartland & Klofat, 1995). Therefore, the findings of this study 
should not be considered directly applicable to SCS technique as defined in the literature 
(D'Ambrogio & Roth, 1997; L. H. Jones, 1981; McPartland & Klofat, 1995). 
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Two additional experimental studies were identified that utilized SCS as part of an investigation 
into osteopathic manipulative therapy (Gamber et al., 2002; Noll et al., 2004). Gamber et al. 
(2002) conducted an observer blinded pragmatic randomly assigned clinical trial of osteopathic 
manipulative therapy (OMT) in patients diagnosed with fibromyalgia syndrome. The SCS 
techniques were consistently applied in combination with other osteopathic techniques to the 
TePs the patient identified as most troublesome. The other osteopathic techniques available to 
the treating osteopath included myofascial release, muscle energy, soft tissue treatment, and 
craniosacral manipulation (Gamber et al., 2002). The amount of time, and number of points 
addressed with SCS were not reported. The authors reported significant improvement in pain 
thresholds post treatment at three locations (left and right second costochondral junction, and the 
left medial epicondyle) for patients receiving SCS in combination with OMT (Gamber et al., 2002). 
From the data reported by Gamber et al. (2002) it is not possible to draw any conclusions as to 
the efficacy of SCS technique.   
 
A number of descriptive articles on SCS have established it is widely utilized clinically as an 
effective osteopathic manipulative technique, although there is limited evidence substantiating the 
assumed efficacy of SCS. Several of the descriptive articles have described specific clinical 
applications for SCS, such as, Complex Regional Pain Syndrome I (CRPS I) following a Grade II 
ankle sprain (Collins, 2007), iliotibial band friction syndrome (Pedowitz, 2005), sacral torsions 
(Cislo, Ramirez, & Schwartz, 1991), low back pain (Lewis & Flynn, 2001), chronic myofascial pain 
(Dardzinski, Ostrov, & Hamann, 2000), foot disorders (L. H. Jones, 1973), and acute ankle 
injuries (Eisenhart, Gaeta, & Yens, 2003). 
 
Collins (2007) reports on the case of a 14 year old with CRPS I following a Grade II ankle sprain, 
and the benefits recorded by way of the analgesic effects of SCS and improved function. A 
decrease of two points on a numeric pain rating scale was reported for overall pain after two 
months, as was, a decrease in tenderness for 10 out of 13 TePs. These analgesic effects were 
considered clinically significant, and are suggestive of the need for more formal investigation. 
Dardzinski et al. (2000) found in a retrospective review of 20 patients suffering from chronic 
localized myofascial pain, the use of the Jones SCS technique could be beneficial in reducing 
pain and improving function. Eisenhart et al (2003) found that SCS could be beneficial in the 
treatment of acute ankle injury. Cleland et al (2005) produced evidence of increased pain free 
grip strength and decreased pain scores after treatment applied to the area of lateral epicondyle 
and the cervicothoracic spine. Lewis & Flynn (2001) reported on four case studies of patients with 
low back pain treated with SCS protocols. The authors reported improvements in the outcomes 
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measured for disability levels (Oswestry Low Back Pain Disability Questionnaire) and pain (McGill 
Pain Questionnaire) in all four cases (Lewis & Flynn, 2001). 
 
Domholdt (2000) has proposed that the primary value of case reports is an effective means for 
practitioners to communicate to scientists. This communication stimulates the progression from 
theory based on anecdotal evidence to theory based on robust research. 
 
In addition, a number of studies have reported the use of SCS as part of an overall osteopathic 
manipulative treatment protocol to treat a variety of disorders including shoulder pain and 
repetitive strain injury of the supraspinatus muscle (Jacobson, Lockwood, Hoefner V, Dickey, & 
Kuchera, 1989), chronic pelvic pain (Tettambel, 2005), chronic pain (Kuchera, 2005), low back 
pain (Licciardone, 2004), arthritis related pain (DeAngelo & Gordin, 2004), and cervicothoracic 
pain (Walko & Janouschek, 1994) and acute or chronically ill hospital patients (Schwartz, 1986). 
Similarly SCS has been reported beneficial when used in conjunction with massage therapy for 
the treatment of temporomandibular joint dysfunction (Eisensmith, 2007). 
 
After reviewing the literature there is a large body of anecdotal and descriptive research in 
support of the effectiveness of SCS technique in clinical practice. To date there are only a few 
peer reviewed RCT articles that provide substantive evidence as to the efficacy of SCS either in 
the short term or long term when compared to either a suitable sham (placebo) or control group. 
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Sports Related Injuries 
Recreational sports people offer a broad heterogeneity of age, occupation and socioeconomic 
group (Stockard, 2001). Recreational sports injuries to the elbow region often involve either 
epicondylalgia or overuse syndromes (Fulcher, Kiefhaber, & Stern, 1998). These injuries are 
most frequently the result of activities that require the elbow and forearm to transmit force to a 
tool; i.e. racquet sports (Gruchow & Pelletier, 1979), rowing (Fulcher et al., 1998), and golf 
(Stockard, 2001). Or to support the body’s weight i.e. cycling (Tucci & Barone, 1988). 
 
The most common injury to amateur golfers is lower back injuries (34.5% of all injuries) followed 
by injuries to the elbow (33.1%), and hand and wrist injuries (34.5% combined). In female golfers, 
elbow injury (35.5%) is even more common than lower back injury (27.4%) (McHardy & Pollard, 
2005; Stockard, 2001). Stockard (2001) reports a wide range of elbow injuries that may be 
present in a golf playing population group, such as; lateral epicondylitis, extensor overload 
injuries, lateral compression injuries, ulnar neuritis associated with medial epicondylitis (up to 
20%), flexor carpi ulnaris tenosynovitis, and possible degenerative change (Stockard, 2001). 
Lateral elbow injuries ('tennis elbow') are more common when compared to medial elbow injuries 
(‘golfer's elbow’) at a ratio of 5:1 (lateral:medial) (McHardy & Pollard, 2005). Sevier and Wilson 
(1999) report that there have been in excess of 40 different treatment methods for lateral 
epicondylitis described in the literature. Physical therapy has been recommended when the 
condition becomes chronic or does not respond to initial treatment.  
 
Outcome Measures 
Visual Analogue Scale for Pain Intensity 
The visual analog scale (VAS) can be used to evaluate a subject’s perception of pain level on a 
horizontal linear scale; this can be interpreted as pain intensity. The VAS is an unmarked 
horizontal line ( generally between 100-130mm in length) with a pain descriptor at each end; “No 
Pain” at one end to “Unbearable Pain” at the other (Yeomans & Liebenson, 1996).  
 
The validity of the VAS as an outcome measure of pain intensity is well established (Crossley, 
Bennell, Cowan, & Green, 2004; Merskey, 1973; Ostelo & de Vet, 2005; Price, Bush, Long, & 
Harkins, 1994; Price, McGrath, Rafii, & Buckingham, 1983; Vicenzino, Collins, Benson, & Wright, 
1998; Yeomans & Liebenson, 1997). The VAS has a high level of responsiveness, reliability, and 
validity permitting detection of clinically relevant changes – an essential measurement for clinical 
trials (Reading, 1980). Bisset, Paungmali, Vicenzino, Beller & Herbet (2005) report that 25 out the 
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28 RCTs accepted in the systematic review and meta-analysis of physical treatments for lateral 
epicondylalgia utilized a VAS for pain as an outcome measure. The VAS measured in millimeters 
on a 100 mm line has a possible 101 response levels, this increases the sensitivity of the VAS 
compared to other measures with more limited response categories (Ostelo & de Vet, 2005). 
Pressure pain threshold 
Pressure algometry is commonly used to quantify measurement of tissue sensitivity (Fischer, 
1987; Fryer, Carub, & McIver, 2004; Fryer & Hodgson, 2005; Reeves et al., 1986). The algometer 
is a calibrated force pressure gauge that can be used to assess the pressure pain threshold 
(PPT) in an individual. There is a body of evidence (Fischer, 1987; Gold, Punnett, & Katz, 2006; 
Maquet, Croisier, Demoulin, & Crielaard, 2004; Ohrbach & Gale, 1989; Reeves et al., 1986) 
supporting the reliability of pressure gauges (algometers) when used to determine PPTs on bony 
and muscular landmarks. The PPT is highly dependant on anatomical location and gender, as 
reported by Maquet et al (2004), for the lateral epicondyle healthy males have a mean PPT = 340 
kPa (3.5 kg/cm2) and healthy females a mean PPT = 250 kPa (2.6 kg/cm2). Kosek, Ekholm & 
Hansson (1999) have noted that great inter-individual variability in PPTs exists in healthy 
subjects.  
 
Fischer (1987) provided evidence of the reproducibility and validity of PPT measurement, with 
identical results obtained from muscles on opposite sides of the body for both male and female 
normal subjects. The use of PPT as an outcome measure was reported in six out of the 28 RCTs 
accepted in the systematic review and meta-analysis of physical treatments for lateral 
epicondylalgia carried out by Bisset et al. (2005). The PPT can be an accurate measure of 
change in tissue sensitivity, when sensitivity is defined as the amount of pressure in kg/cm2 
needed to elicit a change in sensation from pressure to that of discomfort or pain (Nussbaum & 
Downes, 1998; Potter, McCarthy, & Oldham, 2006; Reeves et al., 1986). 
 
Ylinen et al. (2007) reported intra-class correlation coefficients (ICCs) between ‘very large’ and 
‘almost perfect’ (0.78-0.93) for the measurement of PPTs of neck muscles. An ICC is considered 
large (between 0.5 to 0.7), very large (between 0.7 to 0.9) and almost perfect (between 0.9 and 
1.0) (Hopkins, 2002).  Similarly Paungmali et al. (2003) showed reliability correlation coefficients 
ranging in the ‘very large’ category (0.79 to 0.89) for subjects with lateral epicondylalgia. Jones et 
al. (2007) reported a range of ICCs in the ‘almost perfect’ category (0.92 to 0.98) for the 
measurement of PPTs in the upper limb and torso of healthy young women. In a study of PPT for 
subjects with unilateral shoulder and arm pain Vanderweeën et al. (1996) reported ICCs between 
‘large’ to ‘almost perfect’ (0.64 to 0.96). 
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Kosek et al. (1999) showed evidence of lower PPTs over a muscle-nerve site when compared to 
PPT measurements from either bony or pure muscle sites. Further they gave evidence that these 
relationships remain irrespective of skin hypoesthesia, and thus are more likely to be reflective of 
the sensitivity of deeper structures. They conclude that skin pressure pain sensitivity can 
influence the PPT (Kosek et al., 1999). Slater, Arendt-Nielsen, Wright, & Graven-Nielsen (2003) 
documented that the most sensitive sites to pressure of various tissues in and around the elbow 
were the extensor carpi radialis longus origin and the extensor carpi radialis brevis muscle belly. 
They hypothesized that this phenomenon can be explained partially by the increased density of 
nociceptors in these regions compared with other tissues around the elbow. 
 
While pressure algometry has been commonly used in clinical practice for the quantitative 
measurement of tenderness, many variables have been found (such as gender, site of 
application, and application rate) that lead to a high degree of inter-individual variability (Maquet 
et al., 2004; Paungmali, O’Leary et al., 2003). With adequate operator training the site of 
application and application rate can be controlled. Paungmali, O’Leary et al. (2003) demonstrated 
treatment effects after application of a manual therapy intervention for lateral epicondylalgia with 
positive changes in the PPT. In a later paper Paungmali, Vicenzino & Smith (2003) demonstrated 
that repeated application of the manual therapy intervention showed diminished degrees of 
improvement. 
 
Pain-Free Grip Strength 
Pain-free grip strength (PFGS) is defined as the amount of force a subject is able to generate with 
an isometric gripping action before eliciting pain (Paungmali, O’Leary et al., 2003; Pienimäki, 
Siira, & Vanharanta, 2002). Pain-free grip strength is commonly used as an outcome measure for 
the treatment of forearm pain.  Bisset et al. (2005) reported that PFGS was employed as an 
outcome measure in 14 out the 28 RCTs accepted in the systematic review and meta-analysis of 
physical treatments for lateral epicondylalgia. Pain free grip strength has previously been used as 
an outcome measure for physiotherapy RCTs, although it has been noted by Smidt et al. (2002) 
that the specification of grip strength is sometimes not properly reported. 
 
Measurement of PFGS has been shown to be highly reliable and is robust as a measure of 
functional disability for subjects with elbow pain (Hillman et al., 2005; Paungmali, O’Leary et al., 
2003; Paungmali, Vicenzino et al., 2003; Smidt et al., 2002; Stasinopoulos & Stasinopoulos, 
2006). Pienimäki et al. (2002) have shown that increases in grip strength and PFGS correlate well 
with measures of treatment effectiveness for both medial and lateral epicondylitis. Studies 
investigating the examiner reliability of PFGS have reported high intra-observer reliability 
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coefficients (Smidt et al., 2002). Hillman et al. (2005) reported significant differences in PFGS 
between male and female participants in their study. 
 
Minimal Clinically Important Difference 
The minimally clinically important change of the VAS score has been approximated between 30-
35 mm (acute subjects) down to 20-25 mm (sub acute to chronic subjects) (Lee, Hobden, Stiell, & 
Wells, 2003; Ostelo & de Vet, 2005). This is defined as the minimal clinically important difference 
(MCID).  
 
A variety of studies have returned similar figures for the MCID for VAS for pain intensity scores. In 
a pragmatic study of chiropractic intervention for low back pain Garner et al. (2007) reported a 
MCID of 2.3 (95% CI = 1.9-2.6) on a numeric visual analog scale for pain intensity (p<0.008) for 
249 subjects. In a prospective observational study of adult emergency department patients with 
acute pain, Lee et al. (2003) reported a mean reduction in VAS score of 30mm (95% CI = 23.6-
36.4) as representing a clinically important difference in pain severity produced by adequate 
analgesic control in 81% of the subjects. In an investigation of patient’s with chronic back pain 
Mesrian et al. (2007) reported an MCID of  25mm for a VAS for pain intensity. Lee et al. (2003) 
reported a mean reduction in VAS of 30mm demonstrative of a patient’s perception of sufficient 
pain control in relation to administration of parenteral analgesics. Ries (2005) defined a change in 
VAS between 10 to 20mm as the MCID in relation to chronic obstructive pulmonary disease. 
 
Bird & Dickson (2001) developed a variable scale for MCIDs for VAS for pain intensity. Bird & 
Dickson (2001), defined ‘a lot better’ as a change in VAS correlated to the initial value recorded. 
A pre-intervention VAS of up to 33mm would require a post-intervention reduction in VAS of 
>16mm to indicate a perception of ‘a lot better’ for the patient, whereas a pre-intervention VAS of 
between 34mm to 66mm would require a post-intervention reduction in VAS of >33mm, likewise 
an initial VAS of >67mm would require a reduction of >48mm to demonstrate the same change in 
subjectivity (Bird & Dickson, 2001). An issue for consideration in the comparison of a VAS to 
other more scalar measures is described by Fosnocht, Chapman, Swanson & Donaldson (2005). 
The authors report that a change in pain intensity of 10mm as reported on a VAS for pain may not 
be the same subjective experience when the subject decreases a VAS from 40 to 30mm 
compared to a change from 90 to 80mm (Fosnocht et al., 2005).  
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Patients with acute pain in a trauma department were reported as being a ‘little better’ having a 
mean MCID of 13mm (95% confidence interval, 10 to 17mm) on a 100mm VAS (Todd, Funk, 
Funk, & Bonacci, 1996). In their pilot study of acupuncture for low back pain Kennedy et al. 
(2007) proposed an MCID of 20mm through post hoc power analysis. An MCID of 20mm was 
reported by Crossley et al (2004) in their paper investigating the responsiveness of outcome 
measures for the treatment of patellofemoral pain. Kelly (2001) found that there was no statistical 
difference in the MCID for VAS for pain regardless of the pain severity. Kelly stated the MCID 
numerically as 12 mm (95%CI 9 mm to 15 mm) for adult patients in an urban emergency 
department. 
 
The MCID for cancer related break-through pain relief was reported as a 30% decrease in VAS 
score (Farrar, Portenoy, Berlin, Kinman, & Strom, 2000) and similarly for chronic pain sufferers 
30% (Farrar, Young Jr, LaMoreaux, Werth, & Poole, 2001). In a study of myogenous 
temporomandibular disorders van Grootel et al. (2007) reported further evidence in support of an 
MCID at a level of 30%. Haas et al. (2004) in a practice based study of interventions for acute or 
chronic low back pain chose a MCID of 20%.  
 
O’Leary et al. (2007) defined an MCID for pressure pain threshold (PPT) measurement for 
cervical spine muscles as 20%. Their study reported that specific cervical exercises can produce 
immediate changes in local mechanical hyperalgesia in the perceived as pain relief by patients 
with chronic neck pain (O'Leary et al., 2007). In a previous study of reliability of algometry for the 
measurement of PPTs for spinal muscles, Potter et al. (2006) reported that the algometer was a 
reliable single pre- and post- intervention measure, with the MCID for spinal muscles between 35-
40%. In a earlier study of lateral epicondylalgia the Paungmali et al. (2003) reported an increase 
of 15% in PPT as being therapeutically effective, this could be interpreted as the MCID. 
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Sham Protocol 
The blinding of subjects is more likely to be successful if the active treatment closely resembles 
the “light touch” sham intervention (Noll et al., 2004). A potential pitfall in using sham techniques 
is that the sham could be considered as simply another form of generic manipulation, thus diluting 
any treatment effect that may occur with the active intervention. All forms of therapeutic touch  
can elicit beneficial physiological effects, therefore reducing the magnitude of the effect size (Noll 
et al., 2004). It has been reiterated by McPartland et al. (2005) that the ‘slight application of 
human touch and attention’ from the practitioner may induce or contribute beneficial physiological 
responses measurable in the subject. In a review of placebo effects found in pain related studies 
Licciardone (2004) found that there are small, but consistent effects attributable to placebos. 
 
Noll et al (2004) have previously found that blinding to the treatment protocol can be better 
achieved if the sham treatment closely mimics the treatment protocol in application to the same 
body areas, duration and similar sequence of manipulation. A subject’s familiarity with other types 
of manual therapy will not necessarily make them more difficult to blind (Noll et al., 2004). 
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Conclusion 
After reviewing the literature there is a large body of anecdotal and descriptive research in 
support of the effectiveness of SCS technique in clinical practice. To date there are only a few 
peer reviewed randomized controlled trial articles that provide substantive evidence as to the 
efficacy of SCS either in the short term or long term when compared to either a suitable sham 
(placebo) or control group. 
 
People with a history of recreational sports injury to the elbow comprise a suitable symptomatic 
subject group with injuries to areas of the body readily accessible for the collection of data by 
PPT and palpation. When investigating immediate effects of SCS technique it is possible to 
consider at least two outcome measures: 1) the subjective level of pain intensity as reported by a 
VAS (Price et al., 1983); and 2) the objective level of tissue sensitivity as reported by a PPT 
measurement on a TeP (Fischer, 1987). 
 
The VAS is a valid, reliable and highly responsive measure of pain intensity (Price, Harkins, & 
Baker, 1987; Reading, 1980), permitting the detection of clinically relevant changes (also known 
as MCIDs). The VAS for pain intensity has been frequently utilized in studies investigating 
physical treatments for lateral epicondylalgia (Bisset et al., 2005).  
 
Although pressure algometry has been commonly used to quantify changes in tissue sensitivity 
(Fryer et al., 2004; Fryer & Hodgson, 2005), it has not been commonly utilized in studies 
investigating physical treatments for lateral epicondylalgia (Bisset et al., 2005). Random 
allocation of subjects drawn from a heterogeneous pool into intervention and placebo groups may 
control for some of the variables that can effect pressure algometry; such as gender, and site of 
application. The application rate can be partially controlled with prior operator training (Maquet et 
al., 2004; Paungmali, O’Leary et al., 2003). 
 
The reporting of MCIDs for effectiveness and efficacy studies has become more popular, with a 
percentage figure for improvement in VAS for pain intensity (a decrease post-intervention) 
commonly reported (Farrar et al., 2000; Farrar et al., 2001; van Grootel et al., 2007). 
 
The lack of published RCTs analyzing the efficacy of SCS technique to effect pain sensitivity and 
pain intensity of primary TePs in symptomatic subjects makes it difficult to draw any definitive 
conclusions from the literature on this topic. Further studies are required investigating the efficacy 
of SCS technique applied to various body segments of symptomatic subjects. 
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ABSTRACT 
Background and objective: Strain counterstrain (SCS) is an osteopathic technique used by 
osteopaths and manual therapists for the relief of musculoskeletal pain and associated 
dysfunction. Limited literature exists to support the efficacy of SCS technique. The aim of this 
study was to investigate the efficacy of SCS technique on subjects with a history of a recreational 
sports injury of the upper extremity. 
 
Design: Randomized assessor blinded placebo controlled trial. 
 
Methods: Twenty three subjects (13 males, 10 females; mean age=26.1, SD=6.3) fulfilled the 
requirements for the study. Subjects were screened to establish the presence of a primary tender 
point (TeP) around the elbow joint. Subjects were randomly assigned into two groups and 
received either an SCS intervention or a Sham intervention. The primary outcome measures were 
pressure pain threshold (PPT) on the primary TeP, and visual analog scale (VAS) assessing local 
pain intensity elicited by the application of approximately 3kg/cm2 of pressure on the primary TeP. 
The secondary outcome measure was pain-free grip strength (PFGS). 
 
Results: Within group changes showed a significant improvement in VAS for pain intensity 
following the SCS intervention (p<0.001) compared with the Sham intervention (p=0.053). Pre-
post effect sizes for the VAS for pain intensity were ‘large’ in the SCS intervention group (d=1.87) 
and ‘moderate’ (d=0.90) for the Sham intervention group. Both groups surpassed the minimal 
clinically important difference (MCID) defined as a decrease ≥30% in VAS for pain intensity (SCS 
group=55%, Sham group=31%). Within group changes showed a small improvement for PPT at 
the TeP following either the SCS intervention (p=0.497) compared with the sham intervention 
(p=0.749). Pre-post effect sizes for the TeP were small in the SCS intervention group (d=0.29) 
and trivial (d=0.14) for the sham intervention group. No significant differences were found for the 
PFGS (SCS: p=0.936 d=0.03, Sham: p=0.989 d=0.01) 
 
Conclusions: The results indicate that SCS technique may be an efficacious technique in 
treatment of TePs around the elbow in subjects with a history of a recreational sports injury of the 
upper extremity. SCS technique can produce decreases in pain intensity as reported from 
mechanical pressure at a primary TeP. 
 
Key words: strain, counterstrain, pressure pain threshold, osteopathy, visual analog scale 
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INTRODUCTION  
Strain-counterstrain (SCS) is an osteopathic technique first developed by Lawrence Jones in the 
mid 1950s for the treatment of musculoskeletal pain and associated dysfunction.1 The SCS 
technique relies on the identification by physical examination of an active TeP (tender point). A 
TeP has been defined as a small (between 3mm to 10mm in diameter) tense, tender, and 
edematous zone, located deeper in muscle, tendon, ligament, or fascia.1  The SCS technique 
requires a practitioner to position a patient through movement of various joints in three planes so 
that the primary (or chosen) TeP is placed in a position of ease.1-3 The position of ease was 
described as the point whereby TeP pain elicited by mechanical pressure was reduced by at least 
70% from its original tenderness.1 The SCS technique offers a modular diagnostic and treatment 
system that can be practiced in isolation or incorporated as part of other treatment approaches. 
 
Six experimental studies describing the effects of SCS technique in isolation of other osteopathic 
techniques have been reported in the literature. Of these three studies described the immediate 
effects of SCS on pain sensitivity. These studies investigated SCS technique for treating 
myofascial trigger points in the masseter muscle;4 the analgesic effects of SCS technique in the 
treatment of Achilles tendinitis;5 and the analgesic effects of SCS technique in the treatment of 
TePs in the upper trapezius muscle.6 The three remaining studies investigated the longer term 
effects of SCS technique. These studies investigated SCS technique for the treatment of TePs 
found in the hip abductors and adductors,7, 8 and the effectiveness of SCS technique in the 
treatment of plantar fasciitis.9 
 
There have been a number of case reports and other forms of uncontrolled investigation reporting 
specific clinical applications of SCS in treatment of: foot and ankle disorders;10-12 iliotibial band 
friction syndrome;13 sacral torsions;14 low back pain;15 and chronic myofascial pain.16 A number of 
studies have reported the use of SCS as part of an overall osteopathic manipulative treatment 
protocol to address a variety of disorders including shoulder pain and repetitive strain injury of the 
supraspinatus muscle;17 chronic pain;18, 19 low back pain;20 arthritis related pain;21 cervicothoracic 
pain;22 and for the treatment of acute or chronically ill hospital patients.23 
 
We were unable to locate any study in the peer-reviewed literature investigating immediate 
changes in pressure pain thresholds (PPT) in the soft tissues of the elbow following a single 
application of SCS technique to a single TeP located around the elbow joint. The aim of this study 
was to investigate the efficacy of SCS technique on subjects with a history of chronic sports 
related injury to the upper extremity.  
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METHODS 
Design 
A randomized, blinded, placebo controlled experiment, comparing the efficacy of a SCS 
intervention with a Sham intervention for subjects with an undiagnosed chronic sports related 
injury to the upper extremity was conducted in a laboratory setting (refer to figure 1).  
 
Figure 1 Flowchart of Study Design 
Abbreviations: SCS = Strain Counterstrain; TeP = Tender Point; PPT = Pressure Pain Threshold; PFGS = Pain-Free 
Grip Strength; VAS = Visual Analog Scale 
 
Pre-Intervention Outcome Assessment 
Blinded assessment 5 minutes prior to intervention 
Order of PPT assessment: lateral epicondyle, primary TeP, medial 
epicondyle 
Then PFGS for the symptomatic upper limb 
Assessed for Eligibility (n=25) 
Withdrawn (n=1) 
Not meeting inclusion criteria (n=1) 
Randomization (n=24) 
Allocation disclosed to MG for intervention 
SCS Intervention Group (n=12) 
Received allocated intervention (n=12) 
Withdrawn (n=0) 
SCS intervention applied by MG 
VAS for pain intensity recorded for primary TeP 
Analyzed (n=12) 
Sham Intervention Group (n=12) 
Received allocated intervention (n=11) 
Withdrawn failure to blind (n=1) 
Sham intervention applied by MG 
VAS for pain intensity recorded for primary TeP 
Pre-Intervention Examination 
Blinded assessment 5 minutes prior to intervention 
SCS practitioner (MG) was blinded to group allocation 
MG identifies and marks primary TeP 
VAS for pain intensity recorded for primary TeP 
Analyzed (n=11) 
Withdrawn (n=1) 
Withdrawn failure to blind  
 
Pre-Intervention Outcome Assessment 
Blinded assessment 10 minutes post-intervention 
Order of PPT assessment: lateral epicondyle, primary TeP, medial 
epicondyle 
Then PFGS for the symptomatic upper limb 
Pre-Intervention Outcome Assessment 
Blinded assessment 10 minutes post-intervention 
Order of PPT assessment: lateral epicondyle, primary TeP, medial 
epicondyle 
Then PFGS for the symptomatic upper limb 
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Eligibility Criteria 
Twenty five volunteers with a history of chronic sports related injury to the upper extremity 
responded to written notices distributed at the Unitec NZ Mt Albert campus. Before enrolment all 
volunteers completed a general medical questionnaire. Volunteers were excluded if they 
exhibited any of the following: (1) they had signs or symptoms of cervical radiculopathy; (2) they 
had another medical condition that could interfere with the therapy i.e. cardiovascular disease, 
systemic inflammatory disorder, nerve root compression, severe arthritis, or recent surgery; (3) 
they had a history of long term steroid usage; (4) they could not read or write in English; (5) they 
had used analgesics in the previous 24 hours. All subjects gave written informed consent. The 
study was approved by the Unitec Research Ethics Committee.  
 
Pre-Intervention Examination 
All subjects were physically examined by the practitioner (MG) to screen for the presence of 
palpable TePs around the elbow. During the pre-intervention scanning process the practitioner 
was blinded to group allocation (refer to figure 1).  
 
The pre-intervention examination process took approximately 5 minutes, during this time the 
subjects lay supine on a standard treatment plinth. To be included subjects needed to exhibit a 
TeP(s) in one or more of the following locations around the elbow: the common extensor origin on 
the lateral epicondyle; the common flexor origin on the medial epicondyle; the biceps brachii 
aponeurosis; the belly of brachioradialis; the insertion of brachialis; and the insertion of triceps 
brachii on the olecranon process of the ulna. The primary TeP was identified using the SCS 
structural scanning technique for the elbow region, as described by Jones and D’Ambrogio & 
Roth.1, 2 The primary TeP was defined as the TeP which elicited the greatest level of pain as 
reported by the subject in comparison to all other TePs when pressurized by the practitioner’s 
thumb at a level of approximately 3kg/cm.2 The primary TeP was located and marked on the skin 
surface with an ink pen by the practitioner. Subjects completed a visual analog scale (VAS) for 
pain intensity in the pre-intervention prior to assessment of other outcome measures (refer figure 
1). 
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Pre-Intervention Outcomes Assessment 
Following the physical examination subjects moved to a separate assessment cubicle where 
initial pressure pain thresholds (PPTs) and pain-free grip strength (PFGS) data were collected. 
The pre-intervention outcomes assessment took approximately 10 minutes.  
 
The order of anatomical locations for the recording of PPTs was the lateral epicondyle, followed 
by the primary TeP, and then the medial epicondyle. The PPTs for the medial and lateral 
epicondyles were recorded 1) to provide control data for the assessment of any local or regional 
changes in pain sensitivity, and 2) to provide data for the assessment of intra-examiner reliability.  
 
The subject was then assessed for initial PFGS. The assessment of PFGS and PPTs was 
undertaken by a research assistant (RM) who was blinded to group allocation. The principal 
researcher (JH) recorded all outcomes data. After the initial outcomes measurement the group 
allocation was revealed to the practitioner (MG) and the principal researcher (JH). 
 
Sample Size 
Previous studies investigating the immediate effects of manual therapy techniques on lateral 
epicondylalgia and the upper trapezius muscle as measured by PPT have returned moderate to 
large effect sizes.24, 25 The effect size (d=1.20) for this study was based on the work of Fryer & 
Hodgson.25 Using G*Power software (v2.0)26 the a priori sample size for a two tailed t-test for the 
difference between two independent means (two groups) was calculated. Based on an alpha 
error probability of 0.05 and a power (1-β error probability) of 0.80 the minimum sample size 
required was 24 subjects. 
 
Randomization 
Subjects who met all inclusion criteria were randomly assigned using a computer generated 
randomization list to either 1) the SCS intervention group or 2) the Sham intervention group. The 
study utilized assessor-blinded outcomes measurement,27 with the research assistant blinded to 
intervention group assignment for the duration of data collection.  
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Intervention Protocol 
Following pre-intervention measurements, the practitioner (MG), blinded to pre-intervention data, 
applied the allocated intervention to the subject. The practitioner was a trained manual therapist 
with over 10 years experience using SCS in a clinical environment, and is completing a 
postgraduate pre-registration qualification in osteopathy. 
 
SCS Intervention 
The SCS intervention was based on the work of D’Ambrogio & Roth2 and is described for the 
primary TeP as used in this study below: 
1. Pressure was applied to the marked primary TeP site with either one fingertip or the 
thumb to determine the degree of tissue tension; subjects were asked to confirm the 
presence of tenderness. The patient was instructed to relax throughout the intervention. 
2. The practitioner combined movements of the upper limb in several planes while 
monitoring the primary TeP site with either one fingertip or the thumb for relaxation of the 
myofascial tissues. The range of movements employed to effect the elbow joint consisted 
of a selection from the following: compression or distraction, flexion or extension, 
supination or pronation, translation (anterior and posterior), and wrist flexion or wrist 
extension. The practitioner sought verbal confirmation of a reduction in pain intensity 
when applying approximately 3kg/cm2 pressure with either one fingertip or the thumb at 
the primary TeP. 
3. With minimal movements in all directions the practitioner refined the subject’s positioning 
to maximize the reduction of pain as reported by the subject at the primary TeP. The 
subject’s arm was held in this position for a period of approximately 90 seconds. 
4. The subject was instructed to “remain relaxed and not try to help” as the practitioner 
slowly returned the upper limb to a neutral position. 
5. After the intervention the subject then completed another VAS for pain intensity at the 
primary TeP before returning to the assessment cubicle for post-intervention outcomes 
measurement.  
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Sham Intervention 
The Sham intervention was based around the work of D’Ambrogio & Roth2 and is described for 
the primary TeP as used in this study below: 
1. Pressure was applied to the marked primary TeP site with either one fingertip or the 
thumb to determine the degree of tissue tension; subjects were asked to confirm the 
presence of tenderness. The patient was instructed to relax throughout the intervention. 
2. The practitioner combined movements of the upper limb in several planes while 
monitoring the primary TeP site with either one fingertip or the thumb in order to maintain 
tension of the myofascial tissues. The range of movements employed to effect the elbow 
joint consisted of a selection from the following: compression or distraction, flexion or 
extension, supination or pronation, translation (anterior and posterior), and wrist flexion or 
wrist extension. The practitioner sought verbal confirmation that the pain intensity 
remained unchanged when applying approximately 3kg/cm2 pressure with either one 
fingertip or the thumb at the primary TeP. 
3. With minimal movements in all directions the practitioner refined the subject’s positioning 
to maximize the tissue tension and maintain the original level of pain intensity at the 
primary TeP, when approximately 3kg/cm2 pressure was applied. The subject’s arm was 
held in this position for a period of approximately 90 seconds. 
4. The subject was instructed to “remain relaxed and not try to help” as the practitioner 
slowly returned the upper limb to a neutral position. 
5. After the intervention the subject then completed another VAS for pain intensity at the 
primary TeP before returning to the assessment cubicle for post-intervention outcomes 
measurement. 
 
There was a 10 minute interval between the intervention phase (SCS or Sham) and post-
intervention outcomes assessment. 
 
Outcome Measures 
The immediate effects of SCS were investigated using two primary outcome measures:  1) visual 
analog scale (VAS) for pain intensity; 2) algometry for pressure pain threshold (PPT). A strain 
gauge hand dynamometer was used to measure the secondary outcome measure of pain-free 
grip strength (PFGS). The combination of the VAS for pain intensity and PPT for the primary TeP 
offered both a subjective measure and an objective measure of tissue sensitivity. 
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Visual Analogue Scale 
The VAS used was a 130mm horizontal line marked ‘no pain’ to ‘worst pain possible’. Previous 
studies have demonstrated the reliability and construct validity of the VAS by demonstrating 
strong correlations with other self-reported measures of pain intensity.28-30  
 
Subjects were asked to indicate by marking the line at the point that best represented their pain 
intensity when pressure of approximately 3kg/cm2 was applied to their primary TeP by the 
practitioner’s thumb. The subjects were blinded to the result of their pre-intervention VAS when 
completing their post-intervention VAS. The distance from the ‘no pain’ end to the mark made by 
the patient was measured to the nearest millimeter, converted to a score out of 100 and recorded 
as their VAS score of pain intensity. 
 
Pressure Pain Threshold 
The mechanical pressure algometer (Activator Methods Algometer, Activator Methods 
International Ltd, Phoenix AZ) used in this study consisted of a round rubber disk (area 1cm2) 
attached to a pressure (force) gauge. The gauge displays values in kilograms but, the readings 
are expressed in kg/cm2. The range of values of the pressure algometer is 0 to 10 kg/cm2, with 
0.1 kg/cm2 divisions. The rate of pressure increase was maintained at approximately 1kg/cm2/s, 
as described by Fischer31 for mechanical analogue algometers. Downwards pressure was applied 
via the head of the algometer which was perpendicular to the surface of measurement (either the 
marked primary TeP, or the medial and lateral epicondyles). 
 
Subjects were instructed to say ‘now’ or ‘stop’ when they “first began to feel the sensation of 
pressure change to a sensation of discomfort or pain”. The research assistant ceased applying 
pressure at this moment and the principal researcher recorded the pressure value (kg/cm2). Prior 
to measurement the algometer display was covered so that the research assistant could not 
inadvertently see the value; it was uncovered and re-covered by the principal researcher after 
each measurement. The PPT was recorded three times at each point under investigation, with a 
15 second interval between each measurement. The mean PPT was calculated for each of the 
three measurement points in the symptomatic arm and used for analysis. 
 
The PPT measurement was performed 5 minutes prior to the intervention and 10 minutes after 
the intervention by the research assistant. The PPT measurements were recorded while the 
subjects lay in a lateral recumbent position on a standard treatment plinth with their elbows in 90° 
of flexion.32 The examination sequence began with the lateral epicondyle while the subject was 
positioned with their upper limb supported above their flank by a pillow. After measurement of the 
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lateral epicondyle, PPTs were recorded over the primary TeP site, followed by the medial 
epicondyle. To expose the medial surface of the arm the subject was instructed to lie on the side 
of the symptomatic arm. 
 
Pain-Free Grip Strength 
The strain gauge hand dynamometer (Smedley’s Dynamometer, TTM, Tokyo) selected for this 
study measured a range from 0 to 100 kg with 0.5kg divisions. The subject was instructed to lie 
supine with the symptomatic arm at rest on the treatment plinth, when prompted they were asked 
to maximally squeeze the strain gauge hand dynamometer. The symptomatic arm was positioned 
with elbow extended and forearm pronated so that the grip dynamometer could be held 
perpendicular to the treatment table. The research assistant stabilized the dynamometer while the 
principal researcher recorded the maximum effort for PFGS in kg. Subjects received verbal 
encouragement at a consistent level to perform at their maximum effort as described by Martel et 
al.33 Three consecutive measurements were recorded for the symptomatic arm, with a 30 second 
rest period between each. The mean PFGS was calculated and used for analysis. 
 
Reliability 
Intra-class correlation coefficients (ICC) were used to examine the relative reliability of PPT 
measurement for the single blinded assessor, and as a measure of reproducibility.34 The pre-
intervention PPT values from the primary TeP and the medial and lateral epicondyles were 
considered viable data for the calculation of individual ICCs. 
 
ICCs were required for the calculation of the standard error of measurement (SEM) and the 
smallest detectable difference (SDD). The SEM reflects the variability of measurements due to 
repetition and random error, and gives an indication of the absolute reliability of the measures 
used.32, 35 The SDD for the measurements reflects the smallest valid change between the two 
independent measurements that can be detected in a subject.35, 36 The SDD is a clinically 
relevant measure that represents the change that might be expected because of an intervention 
rather than sampling error at the 0.05 level of statistical significance. 
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DATA ANALYSIS 
All VAS for pain intensity data was converted to percentages. Mean and standard deviations (SD) 
were calculated for each variable. Baseline and within-group differences were assessed with a 
paired t-test. Within-group and between group effect sizes (Cohen’s d) were calculated using 
standardized differences in means. The standardized differences in means were calculated by 
taking the difference in the means divided by the mean standard deviation of the groups.34 Effect 
sizes were interpreted according to the following guidelines: d>2.0 was considered ‘very large’; d 
between 1.2 and 2.0 was considered ‘large’; d between 0.6 and 1.2 was considered ‘moderate’; d 
between 0.2 and 0.6 was considered ‘small’; and d<0.2 was considered ‘trivial’.34  
 
The ICCs were calculated using a two-way mixed effects model with a single measure, as all 
subjects were examined by the same assessor (ICC model (3,1)).37 The ICCs were interpreted 
according to the following guidelines: an ICC between 0.0 to 0.1 was considered ‘trivial’; an ICC 
between 0.1 to 0.3 was considered ‘small’; an ICC between 0.3 to 0.5 was considered ‘moderate’; 
an ICC between 0.5 to 0.7 was considered ‘large’; an ICC between 0.7 to 0.9 was considered 
‘very large’; and between 0.9 to 1.0 ‘almost perfect’.34 
 
The standard error of measurement (SEM) was calculated as the square root of the absolute 
error variance ( )( ICCSDSEM −•= 1 ).35, 36 The smallest detectable difference (SDD) was 
calculated using the formula ( SEMSDD ••= 296.1 ).  
 
Based on earlier studies, it was decided that a MCID≥30% would be likely to demonstrate a 
therapeutically important change in the VAS for pain intensity.38-41 The MCID for the VAS for pain 
intensity was compared at a group level and on an individual subject level.  
 
An MCID≥20% was selected for changes in PPT measurement. This is similar to the level of 
change reported by Paungmali et al.42 for changes in PPT for subjects with lateral epicondylalgia. 
It was considered that the sensitivity of the tissues around the elbow more closely reflected the 
responsiveness of cervical spine musculature described by O’Leary et al,43 compared to the 
larger spinal muscle groups assessed by Potter et al.35 
 
Microsoft Office Excel 2003 was used to tabulate raw data, calculate means, SD, effect size, 
SEM and SDD. The ICCs were calculated using SPSS statistical software (SPSS Inc. v 14.0, 
Chicago, Illinois, USA). A p-value less than 0.05 was considered statistically significant. 
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RESULTS 
Subjects 
One volunteer was withdrawn from the study before allocation due to recent anti-inflammatory 
medication use. One subject was withdrawn after allocation to the sham intervention group as a 
result of failure to blind. There were 12 subjects in the SCS intervention group and 11 subjects in 
the sham intervention group (refer to table 1). No significant differences were found between the 
groups for the pre-intervention measures; VAS (p=0.737), PPT for the TeP (p=0.866), PFGS 
(p=0.851). Therefore, it could be assumed that all groups were comparable at the start of the 
study. 
 
Table 1 Baseline Characteristics of Subjects 
 
SCS Intervention Sham Intervention p-value 
Number of subjects (n) 12 11  
Age range: years 18-39 18-40  
Mean (SD) age years  28 (6) 25 (6) 0.285 
Gender: Female 5 5  
Gender: Male 7 6  
Height range: cm 161-189 163.5-179  
Mean (SD) height cm 175.3 (8.8) 172.1 (5.3) 0.296 
Weight range: kg 47-81.5 60-100  
Mean (SD) weight kg  69.6 (10.8) 72.8 (13.4) 0.542 
Dominant Arm Right 12 9  
Dominant Arm Left 0 2  
Symptomatic Arm Right 5 7  
Symptomatic Arm Left 7 4  
VAS between group pre-intervention   0.737 
PPT for Primary TeP pre-intervention   0.866 
PFGS pre-intervention   0.851 
Notes 
VAS = Visual Analog Scale 
PPT = Pressure Pain Threshold 
PFGS = Pain-Free Grip Strength  
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VAS for Pain Intensity 
When the data was compiled by group (SCS or Sham intervention), both groups showed a 
reduction in pain intensity according to the VAS for pain intensity (refer figure 2). Both groups 
satisfied the reduction in VAS≥30% to achieve a MCID (the SCS group showed a 55% reduction 
and the Sham group a 31% reduction). There was a significant and large effect for the SCS group 
(p<0.001; d=1.87) and a less significant but moderate effect for the Sham group (p=0.053; 
d=0.90). At baseline the two groups showed no difference in VAS (p=0.737), whereas the SCS 
group showed a significant lower post-intervention VAS compared to the Sham group (p=0.047; 
d=0.89). Thus, the SCS intervention reduced pain intensity significantly more than the sham 
intervention. 
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Figure 2 Mean group VAS for pain intensity.  
Within group mean scores and the within group effect sizes for both interventions are shown. Both groups showed a mean 
change in VAS for pain Intensity that met the criteria for MCID≥30% change. The SCS group showed a mean reduction in 
VAS for pain intensity of 55% (p<0.001; d=1.87). The Sham group showed a mean reduction in VAS for pain intensity of 
31% (p=0.053; d=0.90). P values were generated using a two-tailed paired t-test, and effect size (d) was generated by 
standardized difference in means.34 
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Individually each subject in the SCS group showed a reduction in VAS for pain intensity, of these, 
10 met the criteria for a MCID≥30% change in VAS (refer figure 3). Nine of the subjects in the 
Sham group showed a decrease in VAS for pain intensity, of these 6 met the criteria for a 
MCID≥30% change in VAS. Two of the subjects in the Sham group showed either no change or a 
minimal increase. 
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Figure 3 Individual mean VAS for pain intensity. 
Individual mean scores and standard deviations for both interventions are shown. Individuals that met the criteria for 
MCID≥30% change are capitalized. Ten subjects in the SCS group showed an individual MCID≥30% in VAS for pain 
intensity (all in a direction that demonstrated a reduction in subjectively assessed pain intensity). Six subjects in the Sham 
group showed individual MCID≥30% in VAS for pain intensity (all in a direction that demonstrated a reduction in 
subjectively assessed pain intensity). 
 
Changes in PPT levels 
As a group there was no statistically significant difference in the primary TeP PPT after either the 
SCS intervention (p=0.497) or the Sham intervention (p=0.749) (refer figure 4). There was a 
‘small’ increase in the threshold (11%; d=0.29) following the SCS intervention, whereas there was 
a ‘trivial’ decrease in the threshold (-3%; d=0.14) following the Sham intervention.  
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Figure 4 Group Means for Primary Tender point PPTs.  
Within group mean scores and the within group effect sizes for both interventions are shown. The SCS group showed a 
mean increase in PPT for TeP of 11% (p=0.497; d=0.29). The Sham group showed a mean reduction in PPT for TeP of 
3% (p=0.749; d=0.14). P values were generated using a two-tailed paired t-test, effect size (d) was generated by 
standardized difference in means.34 On a group level neither group met the criteria for MCID≥20% change. 
 
Individually 5 out of 12 subjects in the SCS group showed a mean change in PPT at the primary 
TeP meeting the criteria of the MCID≥20%, all showed an increase in PPT following the 
intervention [refer figure 6, appendix A]. In the Sham group 2 out of 11 subjects showed a mean 
change in PPT at the primary TeP meeting the criteria of the MCID≥20%, of these one showed an 
increase in PPT, and the other a decrease. 
 
As a group there was no statistically significant difference in the PPT for the medial epicondyle 
after either the SCS intervention (p=0.803; d=0.10) or the Sham intervention (p=0.924; d=0.13) 
[refer figure 7, appendix A]. Individually 2 out of 12 subjects in the SCS group showed a mean 
change in PPT at the medial epicondyle meeting the criteria of the MCID≥20%, one showed an 
increase in PPT following the intervention, the other a decrease [refer figure 8, appendix A]. In the 
Sham group 1 out of 11 subjects showed a mean change in PPT at the medial epicondyle 
meeting the criteria of the MCID≥20%, recording an increase in PPT following the intervention. 
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As a group there was no statistically significant difference in the PPT for the lateral epicondyle 
after either the SCS intervention (p=0.568) or the Sham intervention (p=0.778). There was a 
modest decline of 8% (d=0.24) following the SCS intervention, whereas a trivial improvement of 
4% was noted following the Sham intervention (d=0.12) [refer figure 9, appendix A]. Individually, 6 
out of 12 subjects in the SCS group showed a mean change in PPT at the lateral epicondyle 
meeting the criteria of the MCID≥20%. Two showed an increase in PPT following the intervention; 
the other four a decrease [refer figure 10, appendix A]. In the Sham group 1 out of 11 subjects 
showed a mean change in PPT at the primary TeP meeting the criteria of the MCID≥20%, 
recording an increase in PPT following the intervention. 
 
When all subjects were considered, three subjects allocated to the SCS intervention group 
(subjects T3, T4, and T8) and one subject allocated to the Sham intervention group (subject S7) 
recorded a clinically significant (as defined by the MCID) improvement in both pain intensity and 
PPT for the primary TeP.  
 
Changes in PFGS levels 
As a group (refer figure 5) there was no statistically significant difference in the PFGS after either 
the SCS intervention (p=0.936; d=0.03) or the Sham intervention (p=0.989; d=0.01). With no 
significant difference recorded after intervention between the groups (p=0.778). 
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Figure 5 Group Pain Free Grip Strength.  
Within group mean scores and the within group effect sizes for both interventions are shown. Neither the SCS nor the 
Sham group showed any change in PFGS, SCS group (p=0.936; d=0.03), and Sham group (p=0.989; d=0.01). P values 
were generated using a two-tailed paired t-test; the effect size (d) was generated by standardized difference in means.34 
 
Reliability 
The ICCs, SEM and SDD for the PPT measurements of the primary TeP, and the medial and 
lateral epicondyles are displayed in table 2. The reliability of the research assistant using the 
pressure algometer was ‘very high’.34 
 
Table 2 Reliability indices 
Measure ICC3,1  (LCL-UCL) SEM SDD 
PPT medial epicondyle (kg/cm2) 0.841 (0.712-0.923) 0.806 2.2 
PPT lateral epicondyle (kg/cm2) 0.851 (0.730-0.928) 0.886 2.5 
PPT Primary TeP (kg/cm2) 0.839 (0.709-0.922) 0.519 1.4 
Notes 
PPT = Pressure Pain Threshold  
ICC3,1 = Intra-class Correlation Coefficient 
SEM = Standard Error of Measurement ( )( ICCSDSEM −•= 1 ) 
SDD = Smallest Detectable Difference ( SEMSDD ••= 296.1 ) 
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Table 3 Group and Individual Changes in Context of Smallest Detectable Differences and Minimal Clinically 
Important Difference 
 
SDD SCS Intervention Sham Intervention 
Measure by Group    
     PPT medial epicondyle (kg/cm2) 2.2 0.1 * -0.1 * 
     PPT lateral epicondyle (kg/cm2) 2.5 -0.6 * 0.3 * 
     PPT Primary TeP (kg/cm2) 1.4 0.4 * -0.1 * 
Number individuals Surpass SDD from 
 
Improved(Total) Improved(Total) 
     PPT medial epicondyle  0 0 
     PPT lateral epicondyle  1(5) 1(1) 
     PPT Primary TeP  2(2) 0(1) 
Number individuals Surpass MCID from 
 
Improved(Total) Improved(Total) 
     PPT medial epicondyle  1(2) 1(1) 
     PPT lateral epicondyle  2(6) 1(1) 
     PPT Primary TeP  5(5) 1(2) 
Notes 
PPT = Pressure Pain Threshold  
SDD = Smallest Detectable Difference ( SEMSDD ••= 296.1 ) 
MCID = Minimal Clinically Important Difference for PPT defined as a difference in means (Pre to Post) ≥20% 
Improved(Total) = number of subjects who show beneficial clinical affect (total number of subjects surpassing either   
SDD or MCID whether beneficial or not). 
* Difference in group means to enable comparison with SDD (post-intervention mean – pre-intervention mean) 
 
No group surpassed the SDD required to indicate a clinically significant change in PPT after 
either intervention (refer to table 3). All the individual subjects who surpassed the SDD for PPT at 
either the primary TeP, or medial and lateral epicondyles also surpassed the pre-selected level of 
20% for the MCID (by between 5-58%). 
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DISCUSSION 
In this study we measured an immediate decrease in pain intensity (using VAS) for both groups, 
and an increase in PPT for the SCS group. Effect sizes for the SCS were ‘very large’ for the 
change in pain intensity and ‘small’ for the change in PPT, whereas the effect sizes of the Sham 
group were ‘moderate’ for the change in pain intensity and ‘trivial’ for the change in PPT. 
 
Many previous studies have described the use of SCS in combination with other osteopathic 
techniques for the treatment of a variety of disorders.5, 15, 16, 44, 45 However, only one paper has 
assessed the immediate effects of SCS on TeP sensitivity.6 Meseguer et al.6 dealt with a specific 
muscle, the upper trapezius, in subjects with mechanical neck pain. In the present study, the 
application of the SCS technique was not to a specific muscle, but rather was to the primary TeP 
which was found in a variety of locations around the elbow joint between the different 
symptomatic subjects. The diagnostic TePs in the upper extremity are well suited to experimental 
investigation since they are readily accessible for PPT measurement. Three outcomes measures 
were selected as a means of decreasing the likelihood of a single outcome measure giving rise to 
misleading impressions, as well providing the ability to assess different aspects of the subject’s 
pain experience.46 
 
The position adopted for delivery of the SCS intervention concurs with previous descriptions of 
SCS application where the relevant body segments around the TeP are arranged so as to 
maximize relaxation and reduce tenderness.1, 2 The moderate improvement in pain intensity 
reported by the subjects in the Sham intervention group may be attributed to the effectiveness of 
the Sham intervention producing a placebo effect.  Well designed Sham interventions in manual 
therapy should yield only marginal clinical benefits, and should be inactive and nonspecific in 
comparison to the intervention.47 Due to the nonspecific beneficial effects of touch, the change in 
pain intensity for the Sham group could be attributed to an otherwise unquantified treatment 
effect. Fernández-de-las-Peňas et al.48 reported findings consistent with an earlier review by Hey 
and Helewa49 that no reviewed manual therapy intervention had been more effective than the 
placebo intervention. 
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VAS for Pain Intensity 
Both SCS and Sham groups surpassed the minimal clinically important difference (MCID) of 30% 
for change in VAS for pain intensity, suggesting a strong clinical effect. Several studies have 
reported evidence in support of an MCID for pain intensity (via VAS) as ≥30%.38, 40, 41, 50, 51 
 
Our results agree with those of Meseguer et al.6 who found that SCS was effective in reducing 
tenderness represented by an increase in pressure pain thresholds of TePs in the upper 
trapezius muscle of subjects with mechanical neck pain. Our data is also consistent with the 
findings of Wong & Schauer-Alvarez,8 who found that SCS reduced pain intensity in response to 
manual palpation of TePs in hip musculature.  
 
Changes in PPT levels 
The application of SCS is thought to decrease tissue tenderness by altering nociceptor activity in 
the soft tissues.52 An increase in PPT is synonymous with a decrease in tissue sensitivity,35, 53, 54 
thus the increase in PPT in response to SCS technique provides a measure of the analgesic 
effect of SCS.35, 55 Based on previous literature and our current findings, it appears that SCS 
techniques have the capacity to provide immediate relief of tenderness and local pain provoked 
by TePs. 
 
Other authors investigating the effectiveness of manual therapy techniques to increase PPT 
levels at the elbow have reported improvements ranging from 10% to 20%.24, 42, 56 Such findings 
provide evidence that manual therapy directed to the cervical spine, or to the elbow joint, can 
both result in analgesic effects at the elbow. 
 
Bailey & Dick52 proposed a nociceptive hypothesis that tissue damage in dysfunctional muscles 
can be reduced by the positional release mechanism utilized by SCS. They suggest that 
relaxation of the damaged tissues may be achieved by placing patients in a position of ease 
which may advance local perfusion of fluids (i.e. blood, and lymph) and enhance the removal of 
sensitizing inflammatory mediators. 
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Jones et al.57 reported a decrease in PPT levels when assessing repeated outcome 
measurements on the same anatomical locations over successive days. They reported no 
significant change in PPT levels after repeated pressure algometry measurements on the same 
anatomical location on the same day.57 It is therefore reasonable to conclude that an 
improvement in PPT demonstrated immediately after an intervention can be attributed to a 
treatment effect rather than an effect of the testing process. 
 
Changes in PFGS levels 
In our study the maximal grip strength, as represented by the pain free grip strength, showed no 
significant changes between pre- and post- intervention measurement. This could be a reflection 
of the limited sensitivity of the measuring instrument, or the level of discomfort reported by the 
subjects before reaching what they felt was a true maximum effort.  
 
Our results concur with the findings of Slater et al.58 who were unable to demonstrate an increase 
in maximal force post treatment in subjects with experimentally induced lateral epicondylalgia. 
Authors of previous studies have been able to demonstrate a clinically important improvement in 
PFGS after treatment for subjects with lateral epicondylalgia.59-61 
 
Reliability 
The intra-class correlation coefficient (ICC) for our baseline data recorded for both the medial and 
lateral epicondyles showed good test re-test reliability for our single blinded assessor. The ICCs 
compare favorably with those described in earlier studies utilizing PPT measurement.42, 55, 57, 62 
The smallest detectable difference (SDD) for the lateral and medial epicondyles was similar to 
that reported by Smidt et al.,36 and the SDD for the primary TeP was higher than the MCID≥15% 
reported by Paungmali et al.42 for lateral epicondylalgia which may reflect the level of sensitivity 
associated with our choice of subjects.  
 
All the individual subjects who surpassed the SDD for PPT at either the primary TeP, or medial 
and lateral epicondyles also surpassed the pre-selected level of MCID. This would suggest that 
the MCID was at a suitable level for the sensitive tissues around the elbow in subjects with a 
chronic sports related injury to the upper extremity. 
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Limitations 
This study has several limitations. Only the TePs pertaining to the elbow joint were included for 
treatment.  Interestingly, there has been evidence of beneficial effects in treating the cervical 
spine in relation to elbow pain.61 Therefore, further studies are needed to examine the distal 
effects of SCS interventions when applied to TePs found in the spine. 
 
It was sometimes difficult to accurately apply the algometer to match the angle of the TeP 
palpated in soft tissues; this was due in part to the shape of the algometer applicator head but 
was also related to difficulty localizing the algometer to precisely the same point. The increase of 
pressure for the measurement of PPT was maintained at an approximate rate. The research 
assistant had received prior training in the application of the algometer at approximately 
1kg/cm2/s. Future studies utilizing finger tip flexible pressure meters as described by Marcotte et 
al.63 may circumvent these problems as: 1) the application of a finger tip sensor allows the 
assessor a greater degree of sensitivity to accurately locate the pressure sensor, and 2) an 
electronic device can accurately display the rate of increase in pressure.  
 
There is not yet a strong enough body of evidence to rule out the likelihood the perception of TeP 
pain can be changing over time for symptomatic subjects. It follows that in order to rule out the 
negative changes for pressure algometry reported in this study as being due to possible irritation 
caused by the of the testing process a third group is required. Future studies could include a third 
group to compare against the sham and SCS intervention groups. This group could act as a 
control receiving no intervention, so as to quantify the placebo effect attributable to the sham 
intervention. 
 
The results in this study may have been limited by the choice of outcome measure; the VAS is a 
valid clinical measure,54 but could have become a source of error if the subjects were biased by 
the ability to remember their previous scores due to the short time period between pre- and post- 
recording.6 Future studies could investigate the longer-term effects of this intervention, so that 
outcome measurement would occur after greater time periods. 
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Conclusion 
We have demonstrated a significant decrease (54%) in VAS for pain intensity with an associated 
increase in PPT for the SCS group in our study. The improvement in PPT for the SCS and Sham 
groups was below the MCID. Our results suggest that SCS was efficacious in reducing 
tenderness of TePs around the elbow in subjects presenting with mechanical pain related to a 
sports related injury.  
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Figure 6 Individual mean PPT for tender point.  
Individual mean scores and standard deviations for both interventions are shown. Individuals that met the criteria for 
MCID≥20% change are capitalized. Five subjects in the SCS group showed an individual MCID≥20% in PPT for the 
primary TeP (all in a direction that demonstrated a reduction in objectively assessed pain intensity). Two subjects in the 
Sham group showed individual MCID≥20% in PPT for the primary TeP (one in a direction that demonstrated a reduction in 
objectively assessed pain intensity, the other showed an objective increase in assessed pain intensity). 
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Figure 7 Group Means for Medial Epicondyle PPTs.  
Within group mean scores and the within group effect sizes for both interventions are shown. P values were generated 
using a two-tailed paired t-test, effect size (d) was generated by standardized difference in means.34 On a group level 
neither group met the criteria for MCID≥20% change. 
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Figure 8 Individual mean PPT for medial epicondyle.  
Individual mean scores and standard deviations for both interventions are shown. Individuals that met the criteria for 
MCID≥20% change are capitalized. Two subjects in the SCS group showed an individual MCID≥20% in PPT for the 
medial epicondyle (one in a direction that demonstrated a reduction in objectively assessed pain intensity, the other 
showed an objective increase in assessed pain intensity).One subject in the Sham group showed individual MCID≥20% in 
PPT for the medial epicondyle (in a direction that demonstrated a reduction in objectively assessed pain intensity). 
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Figure 9 Group Means for Lateral Epicondyle PPTs.  
Within group mean scores and the within group effect sizes for both interventions are shown. P values were generated 
using a two-tailed paired t-test, effect size (d) was generated by standardized difference in means.34 On a group level 
neither group met the criteria for MCID≥20% change. 
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Figure 10 Individual mean PPT for lateral epicondyle. 
Individual mean scores and standard deviations for both interventions are shown. Individuals that met the criteria for 
MCID≥20% change are capitalized. Six subjects in the SCS group showed an individual MCID≥20% in PPT for the lateral 
epicondyle (two in a direction that demonstrated a reduction in objectively assessed pain intensity, four showed an 
objective increase in assessed pain intensity).One subject in the Sham group showed individual MCID≥20% in PPT for 
the lateral epicondyle (in a direction that demonstrated a reduction in objectively assessed pain intensity). 
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Appendix B - Ethics Resources 
 
 
 
 
 
 
An Investigation into the Efficacy of Strain Counterstrain Technique to 
Produce Hypoalgesic Effects in Symptomatic Subjects 
 
Information Sheet 
 
About the research 
You are invited to take part in a research project being undertaken as part of the Masters of Osteopathy 
Degree. This information sheet is designed to inform you as to the nature of the research and what will 
happen should you choose to take part. 
The purpose of this research is to investigate how well an osteopathic technique called Strain-Counterstrain 
can reduce pain and improve the functioning of a forearm injury sustained by a recreational sports person. 
We are recruiting subjects who have sustained such a sports related injury. It is hoped that the information 
gained from this research will help osteopaths when making technique decisions in the treatment of patients. 
Strain-Counterstrain is an indirect technique, this means that the patient’s arm will be moved by a trained 
practitioner into a position of comfort, and held in this position for 90 seconds and returned to a rest position. 
During the Strain-Counterstrain technique the participant is only required to relax. 
 
The researchers 
The researcher is James Hutchinson. Dr Carol Horgan and Dr Graham Fordy are supervising the research 
project. 
 
What will participation involve? 
• To currently have a forearm injury sustained while playing some form of recreational sports. 
• Read and complete a screening questionnaire on General Health and Musculoskeletal Injuries that may 
prevent you from receiving a Strain-Counterstrain technique.  
• Be available for one data collection session lasting up to 1 ½ hours. 
• The research will require you to grip a measurement instrument to test your grip strength before you feel 
pain. A trained assessor will also apply pressure to an identified tender point on your forearm until you 
experience discomfort. This testing process will be repeated before and after treatment in order to assess the 
treatment’s effectiveness. Data will be collected from both of your arms for comparison. 
• As this is an experimental design research you may be randomly assigned to either a treatment group to 
receive the Strain-Counterstrain technique or another osteopathic technique. You will not be informed of the 
type of technique you received until the end of data collection, as the experimental method requires that this 
information is concealed from you until after treatment and data collection has finished. 
• All participants will receive one complementary follow-up treatment session with the principal researcher, 
one week after data collection or at a later date that suits. 
• In order to participate all subjects are required to sign a consent form. 
• The research requires a participant to remove any superficial clothing covering the upper body 
(shirts/blouses etc), from the waist up [NOT underwear]. 
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• For the purpose of data collection three to five anatomical landmarks will be marked with coloured non-
permanent (non-toxic) felt tipped pens on various parts of your forearms. 
• There will be no sudden movements and your comfort will be monitored. You will be allowed rest breaks, as 
you require them. You are free to withdraw from the sessions at any point and do not need to state a reason for 
doing so.  
• Consent to the research team’s use of the research data in preparing both a research project dissertation 
and an article for publication (all data will be anonymous).  
• Consent to the storage of your anonymous research data indefinitely for future research.  
 
Getting help 
Please contact either one of us should you require help with this research project. 
 
James Hutchinson  Email:  jamesrhutchinson@gmail.com Phone: 027 3498919 
Dr Carol Horgan  E- mail chorgan@unitec.ac.nz 
Dr Graham Fordy  Email:  gfordy@unitec.ac.nz  Phone: (09) 815 4321 ext 7908 
 
Potential risks to research participants 
There is no known published data indicating any risks associated with this research.  However, the 
researcher accepts that it is possible there may be some undetermined risks involved in the research 
process.  In the case that any potential risk of harm should arise for any research participant, it will be 
treated on an individual basis.  In any such case the research process will be halted immediately. 
 
Confidentiality 
Confidentiality and your anonymity will be protected in the following ways: 
• Only the researchers will see completed questionnaires and consent forms.   
• All forms will be stored in a locked file.  Only the researchers will have access to this file.   
• Any data derived from the research will be anonymous and your identity will be kept confidential.  
You have the right not to participate, or withdraw from this research project at any time up until the 
point of data analysis (2 weeks after the last session).  Contact James Hutchinson or Dr Carol 
Horgan that you no longer wish to participate by telephone or email, or by telling us when we 
contact you. 
A copy of the final report will be available at the Unitec New Zealand library. All participants are 
welcome to view this. Summaries and recommendations may be published in research journals. 
 
Information and concerns 
If you want further information about the project, you can call or email the above addresses. 
At anytime if you are concerned or confused about the research project you may contact James Hutchinson, 
the primary researcher on the details above. 
 
If you have concerns about the way in which the research is being conducted you can 
contact the following: 
Health Advocates: Advocates Network Services Trust, Phone (09) 623 5799, 0800 205 555, Fax (09) 623 5798, PO Box 9983, 
Newmarket, Auckland. 
Finally, we would like to thank you for your valuable contribution to this research.  
 
This study has been approved by the Unitec Research Ethics Committee from March 2007 to December 2007.  If you have any 
complaints or reservations about the ethical conduct of this research, you may contact the Committee through the Secretary (ph: 
09 815-4321 ext 8041).  Any issues you raise will be treated in confidence and investigated fully, and you will be informed of the 
outcome. 
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Screening Questionnaire for General Health and Musculoskeletal Injury History 
 
1. Are you between the ages of 20 to 70 years old? 
 
2. Have you currently or are you receiving treatment for another musculoskeletal 
disorder that is more “troublesome” than your upper limb pain? 
 
3. Have you experienced any neck pain that travels past the tip of your shoulder? 
Have you experienced any pins & needles or numbness in your arm since the 
injury? 
 
4. Are you currently taking any prescription pain medication or unable to refrain from 
using any over the counter analgesics? 
 
5. Have you been diagnosed, treated and/or medicated for any circulatory, blood or 
heart conditions in the last 10 years? 
Including any of the following: 
Arteriosclerosis/Atherosclerosis 
Coronary Artery Disease / Angina / Aneurysm 
High Blood Pressure (Hypertension), if controlled by diet leave blank 
Pericarditis / Rheumatic Fever 
Blood Clots / Deep Vein Thrombosis (exclude single attack) 
 
6. Have you been diagnosed, treated and/or medicated for any serious digestive 
conditions in the last 10 years? 
 
7. Have you been diagnosed, treated and/or medicated for endocrine, lymphatic or 
metabolic conditions in the last 10 years? 
Including the long term use of steroids. 
 
8. Are you currently receiving treatment or have received treatment within the last 
month for any muscle, skeletal or skin conditions? 
Including any of the following: 
Arthritis (chronic or severe osteo- or rheumatoid arthritis includes Ankylosing Spondylitis, 
Degenerative Disk Disease, and Psoriatic Arthritis; includes conditions that are controlled 
by aspirin or over-the-counter non-steroidal anti-inflammatory agents) 
Bone Disorders (includes Osteoporosis, hip dysplasia, fractures, or bone spurs) 
Cartilage/Ligament/Tendon Conditions (includes Chondritis, or Dupuytren’s Contracture 
(in hands) 
Synovitis (which is a joint lining inflammation, includes Tendonitis or Tendinitis; 
Tendonitis of Thumb (De Quervain’s Disease) 
Surgery 
 
9. Have you been diagnosed, treated and/or medicated for any non-psychiatric 
nervous system conditions in the last 10 years? 
Including any of the following: 
Carpal Tunnel Syndrome 
Thoracic Outlet Syndrome 
 
10. Have you been diagnosed, treated and/or medicated for any respiratory system 
conditions in the last 10 years? 
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An Investigation into the Efficacy of Strain Counterstrain Technique to 
Produce Hypoalgesic Effects in Symptomatic Subjects 
 
Consent Form 
 
This research project investigates the efficacy of strain counterstrain technique to improve function and pain-
free status of the forearm in a symptomatic population. The research is being undertaken by James 
Hutchinson from Unitec New Zealand, and will be supervised by Dr Carol Horgan and Robert Moran. 
 
Name of Participant:…………………………………………………………………………. 
 
I have seen the Information Sheet dated October 2006 for people wishing to participate in the project 
investigating the efficacy of Strain Counterstrain technique to produce hypoalgesia in symptomatic subjects.  
 
I have had the opportunity to read the contents of the information sheet and to discuss the project with the 
researchers and I am satisfied with the explanations I have been given. 
 
I understand that taking part in this project is voluntary (my choice) and that I may withdraw up until the point 
at which data analysis is started and this will in no way affect my access to the services provided by Unitec 
New Zealand or any other support service.  
 
I understand that I can withdraw from the experiment if, for any reason, I want this. 
 
I understand that my participation in this project is confidential and that no material that could identify me will 
be used in any reports on this project. 
 
I have had enough time to consider whether I want to take part. 
 
I know whom to contact if I have any questions or concerns about the project 
 
The principal researcher and first contact for this project is: 
James Hutchinson  
027 349 8919 
mailto:jamesrhutchinson@gmail.com 
 
Signature………………………………………………….participant   ………. (Date) 
 
Project explained by…………………………………… 
 
Signature……………………………………………….                   …………... (Date) 
 
The participant should retain a copy of this consent form. 
 
This study has been approved by the Unitec Research Ethics Committee from March 2007 to December 2007.  If you have any 
complaints or reservations about the ethical conduct of this research, you may contact the Committee through the Secretary (ph: 
09 815-4321 ext 8041).  Any issues you raise will be treated in confidence and investigated fully, and you will be informed of the 
outcome. 
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Appendix C – Instructions for authors for manuscript 
submission 
INTERNATIONAL JOURNAL OF OSTEOPATHIC MEDICINE 
Former title: Journal of Osteopathic Medicine 
 
Guide for Authors  
The journal Editors welcome contributions for publication from the following categories: Letters to 
the Editor, Reviews and Original Articles, Commentaries and Clinical Practice case studies with 
educational value. 
 
Online Submission  
Submission to this journal proceeds totally online.(  http://ees.elsevier.com/ijom) you will be 
guided stepwise through the creation and uploading of the various files. The system automatically 
converts source files to a single Adobe Acrobat PDF version of the article, which is used in the 
peer-review process. Please note that even though manuscript source files are converted to PDF 
at submission for the review process, these source files are needed for further processing after 
acceptance. All correspondence, including notification of the Editor's decision and requests for 
revision, takes place by e-mail and via the Author's homepage, removing the need for a hard-
copy paper trail. 
 
The above represents a very brief outline of this form of submission. It can be advantageous to 
print this "Guide for Authors" section from the site for reference in the subsequent stages of 
article preparation. 
 
Submission of an article implies that the work described has not been published previously 
(except in the form of an abstract or as part of a published lecture or academic thesis), that it is 
not under consideration for publication elsewhere, that its publication is approved by all authors 
and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if 
accepted, it will not be published elsewhere in the same form, in English or in any other language, 
without the written consent of the Publisher. 
 
Types of contributions 
Letters to the Editor As is common in biomedical journals the editorial board welcomes critical 
response to any aspect of the journal. In particular, letters that point out deficiencies and that add 
to, or further clarify points made in a recently published work, are welcomed. The Editorial Board 
reserves the right to offer authors of papers the right of rebuttal, which may be published 
alongside the letter. 
 
Reviews and Original Articles These should be either i) reports of new findings related to 
osteopathic medicine that are supported by research evidence. These should be original, 
previously unpublished works. The report will normally be divided into the following sections: 
abstract, introduction, materials and methods, results, discussion, conclusion, references. Or ii) 
critical or systematic review that seeks to summarise or draw conclusions from the established 
literature on a topic relevant to osteopathic medicine. 
 
Short review The drawing together of present knowledge in a subject area, in order to provide a 
background for the reader not currently versed in the literature of a particular topic. Shorter in 
length than and not intended to be as comprehensive as that of the literature review paper. With 
more emphasis on outlining areas of deficit in the current literature that warrant further 
investigation. 
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Research Note Findings of interest arising from a larger study but not the primary aim of the 
research endeavour, for example short experiments aimed at establishing the reliability of new 
equipment used in the primary experiment or other incidental findings of interest, arising from, but 
not the topic of the primary research. Including further clarification of an experimental protocol 
after addition of further controls, or statistical reassessment of raw data. 
 
Preliminary Findings Presentation of results from pilot studies which may establish a solid basis 
for further investigations. Format similar to original research report but with more emphasis in 
discussion of future studies and hypotheses arising from pilot study. 
 
Commentaries Include articles that do not fit into the above criteria as original research. Includes 
commentary and essays especially in regards to history, philosophy, professional, educational, 
clinical, ethical, political and legal aspects of osteopathic medicine. 
 
Clinical Practice Authors are encouraged to submit papers in one of the following formats: Case 
Report, Case Problem, and Evidence in Practice. 
 
Case Reports usually document the management of one patient, with an emphasis on 
presentations that are unusual, rare or where there was an unexpected response to treatment eg. 
an unexpected side effect or adverse reaction. Authors may also wish to present a case series 
where multiple occurrences of a similar phenomenon are documented. Preference will be given to 
reports that are prospective in their planning and utilise Single System Designs, including 
objective measures. 
 
The aim of the Case Problem is to provide a more thorough discussion of the differential 
diagnosis of a clinical problem. The emphasis is on the clinical reasoning and logic employed in 
the diagnostic process. 
 
The purpose of the Evidence in Practice report is to provide an account of the application of the 
recognised Evidence Based Medicine process to a real clinical problem. The paper should be 
written with reference to each of the following five steps: 1. Developing an answerable clinical 
question. 2. The processes employed in searching the literature for evidence. 3. The appraisal of 
evidence for usefulness and applicability. 4. Integrating the critical appraisal with existing clinical 
expertise and with the patient's unique biology, values, and circumstances. 5. Reflect on the 
process (steps 1-4), evaluating effectiveness, and identifying deficiencies. 
 
Presentation of Typescripts 
Your article should be typed on A4 paper, double-spaced with margins of at least 3cm. Number 
all pages consecutively beginning with the title page. 
 
To facilitate anonymity, the author's names and any reference to their addresses should only 
appear on the title page. Please check your typescript carefully before you send it off, both for 
correct content and typographic errors. It is not possible to change the content of accepted 
typescripts during production. 
 
Papers should be set out as follows, with each section beginning on a separate page: 
 
Title page  
To facilitate the peer-review process, two title pages are required. The first should carry just the 
title of the paper and no information that might identify the author or institution. The second 
should contain the following information: title of paper; full name(s) and address(es) of author(s) 
clearly indicating who is the corresponding author; you should give a maximum of four 
degrees/qualifications for each author and the current relevant appointment only; institutional 
affiliation; name, address, telephone, fax and e-mail of the corresponding author; source(s) of 
support in the form of funding and/or equipment. 
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Keywords  
Include three to ten keywords. These should be indexing terms that may be published with the 
abstract with the aim of increasing the likely accessibility of your paper to potential readers 
searching the literature. Therefore, ensure keywords are descriptive of the study. Refer to 
http://www.nlm.nih.gov/mesh/meshhome.html for the MeSH thesaurus. 
 
Abstract  
Both qualitative and quantitative research approaches should be accompanied by a structured 
abstract. Commentaries and Essays may continue to use text based abstracts of no more than 
150 words. All original articles should include the following headings in the abstract as 
appropriate: Background, Objective, Design, Setting, Methods, Subjects, Results, and 
Conclusions. As an absolute minimum: Objectives, Methods, Results, and Conclusions must be 
provided for all original articles. Abstracts for reviews of the literature (in particular systematic 
reviews and meta-analysis) should include the following headings as appropriate: Objectives, 
Data Sources, Study Selection, Data Extraction, Data Synthesis, Conclusions. Abstracts for Case 
Studies should include the following headings as appropriate: Background, Objectives, Clinical 
Features, Intervention and Outcomes, Conclusions. 
 
Text  
The text of observational and experimental articles is usually, but not necessarily, divided into 
sections with the headings; introduction, methods, results, results and discussion. In longer 
articles, headings should be used only to enhance the readability. Three categories of headings 
should be used: 
 
•major ones should be typed in capital letter in the centre of the page and underlined 
•secondary ones should be typed in lower case (with an initial capital letter) in the left hand 
margin and underlined 
•minor ones typed in lower case and italicised 
 
Do not use 'he', 'his' etc. here the sex of the person is unknown; say 'the patient' etc. Avoid 
inelegant alternatives such as 'he/she'. Avoid sexist language. 
 
References  
Responsibility for the accuracy of bibliographic citations lies entirely with the Authors. 
 
Citations in the text: Please ensure that every reference cited in the text is also present in the 
reference list (and vice versa). Avoid using references in the abstract. Unpublished results and 
personal communications are not recommended in the reference list, but may be mentioned in 
the text. If these references are included in the reference list they should follow the standard 
reference style of the journal and should include a substitution of the publication date with either 
"Unpublished results" or "Personal communication" Citation of a reference as "in press" implies 
that the item has been accepted for publication. 
 
Text: Indicate references by superscript numbers in the text. The actual Authors can be referred 
to, but the reference number(s) must always be given. 
 
List: Number the references in the list in the order in which they appear in the text. 
 
Examples: 
Reference to a journal publication: 
1. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 
2000;163:51-9. 
 
Reference to a book: 
2. Strunk Jr W, White EB. The elements of style. 3rd ed. New York: Macmillan; 1979. 
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Reference to a chapter in an edited book: 
3. Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, 
Smith RZ, editors. Introduction to the electronic age. New York: E-Publishing Inc; 1999, p. 281-
304 
 
Note shortened form for last page number. e.g., 51-9, and that for more than 6 Authors the first 6 
should be listed followed by "et al." For further details you are referred to "Uniform Requirements 
for Manuscripts submitted to Biomedical Journals" (J Am Med Assoc 1997;277:927-934) (see 
also http://www.nejm.org/general/text/requirements/1.htm) 
 
Citing and listing of Web references. As a minimum, the full URL should be given. Any further 
information, if known (Author names, dates, reference to a source publication, etc.), should also 
be given. Web references can be listed separately (e.g., after the reference list) under a different 
heading if desired, or can be included in the reference list. 
 
Tables, Illustrations and Figures 
A detailed guide on electronic artwork is available on our website: http://elsevier.com/authors  
 
Preparation of supplementary data. Elsevier now accepts electronic supplementary material (e-
components) to support and enhance your scientific research. Supplementary files offer the 
Author additional possibilities to publish supporting applications, movies, animation sequences, 
high-resolution images, background datasets, sound clips and more. Supplementary files 
supplied will be published online alongside the electronic version of your article in Elsevier Web 
products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your 
submitted material is directly usable, please ensure that data is provided in one of our 
recommended file formats. Authors should submit the material in electronic format together with 
the article and supply a concise and descriptive caption for each file. For more detailed 
instructions please visit our artwork instruction pages at http://www.elsevier.com/authors. 
 
Illustrations and tables that have appeared elsewhere must be accompanied by written 
permission to reproduce them from the original publishers. This is necessary even if you are an 
author of the borrowed material. Borrowed material should be acknowledged in the captions in 
the exact wording required by the copyright holder. If not specified, use this style: `Reproduced by 
kind permission of . . . (publishers) from . . . (reference).' Identifiable clinical photographs must 
be accompanied by written permission from the patient. 
 
The text of original research for a quantitative or qualitative study is typically subdivided into the 
following sections: 
 
Introduction 
State the purpose of the article. Summarise the rationale for the study or observation. Give only 
strictly pertinent references and do not review the subject extensively. Do not include data or 
conclusions from the work being reported. 
 
Materials and Methods 
Describe your selection of observational or experimental subjects (including controls). Identify the 
methods, apparatus (manufacturer's name and address in parenthesis) and procedures in 
sufficient detail to allow workers to reproduce the results. Give references and brief descriptions 
for methods that have been published but are not well known; describe new methods and 
evaluate limitations. 
 
Indicate whether procedures followed were in accordance with the ethical standards of the 
institution or regional committee responsible for ethical standards. Do not use patient names or 
initials. Take care to mask the identity of any subjects in illustrative material. 
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Results 
Present results in logical sequence in the text, tables and illustrations. Do not repeat in the text all 
the data in the tables or illustrations. Emphasise or summarise only important observations. 
 
Discussion 
Emphasise the new and important aspects of the study and the conclusions that follow from 
them. Do not repeat in detail data or other material given in the introduction or the results section. 
Include implications of the findings and their limitations, include implications for future research. 
Relate the observations to other relevant studies. Link the conclusion with the goals of the study, 
but avoid unqualified statements and conclusions not completely supported by your data. State 
new hypothesis when warranted, but clearly label them as such. Recommendations, when 
appropriate, may be included. 
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named in this section must have given their permission to be named. Authors are responsible for 
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endorsement of the data and conclusions. 
 
IJOM Author Contribution Statement 
All manuscripts submitted to the journal should be accompanied by an Author Contribution 
Statement. The purpose of the Statement is to give appropriate credit to each author for their role 
in the study. All persons listed as authors should have made substantive intellectual contributions 
to the research. To qualify for authorship each person listed should have made contributions in 
each of the following; 
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2) Drafting of manuscript, or critical revision for important intellectual content; 
3) All authors must have given approval to the final version of the manuscript submitted for 
consideration to publish. 
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sufficient justification for authorship. Contributors who do not meet the criteria for authorship as 
outlined above should be listed in the Acknowledgements section. Acknowledgements may 
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resources and funding. The statement may be published in the paper as appropriate. 
Example of suggested format. Note the use of author initials. 
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multi-authored papers) by PDF wherever possible and should be returned within 48 hours of 
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